- $9.04bn
- $9.10bn
- $4.64bn
Annual income statement for Acuity, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2022 August 31st | 2023 August 31st | 2024 August 31st | 2025 August 31st | 2026 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Preliminary |
| Revenue | |||||
| Total Revenue | 4,006 | 3,952 | 3,841 | 4,346 | 4,642 |
| Cost of Revenue | |||||
| Gross Profit | 1,673 | 1,713 | 1,782 | 2,079 | 2,299 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3,496 | 3,479 | 3,288 | 3,782 | 3,928 |
| Operating Profit | 510 | 473 | 553 | 564 | 714 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 494 | 447 | 549 | 500 | 681 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 384 | 346 | 423 | 397 | 531 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 384 | 346 | 423 | 397 | 531 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 384 | 346 | 423 | 397 | 531 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 11.1 | 11.4 | 13.5 | 13.9 | 17 |
| Dividends per Share |